Kexing Biopharm Co., Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application (IND) of GB05, Human Interferon α1b Inhalation Solution, a self-developed product by ...
Recruitment completed and all doses administered for VYD2311 ongoing Phase 1/2 clinical trial (40 subjects) evaluating 3 routes of administrationPhase 1/2 clinical data for VYD2311 to date are positiv ...
With its patented sublingual interferon technology, Ainos is poised to redefine antiviral treatment standards ... eliminating the need for injections. • Flexible Dosage Forms: Includes lozenges ...
and these authors have now shown that intravenous injection of antiviral small interfering RNA (siRNA) bound to a short virus-derived peptide offers protection against fatal viral encephalitis in ...
Citation: Flu antiviral baloxavir shows promise over other treatments for high-risk patients, shortening symptom duration (2025, January 16) retrieved 9 February 2025 from https://medicalxpress ...
Hosted on MSN1mon
Most Antiviral Drugs Showed Limited or No Effects Against FluAntiviral drugs commonly used to treat non-severe influenza appeared to have little or no effect on key clinical outcomes, except for baloxavir (Xofluza), according to a systematic review and meta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback